ROLE OF NEUROMODULATION IN MIGRAINE
The RELIEV-CM2 clinical study will investigate the first-ever, head located implantable neuromodulation devicedesigned to treat Chronic Migraine.
The RELIEV-CM2 clinical study will investigate the first-ever, head located implantable neuromodulation devicedesigned to treat Chronic Migraine.
The comorbidity, co-prescribing, and co-occurrence of disability among persons with chronic pain create greater challenges in managing each condition and reducing impact. Pain cannot be managed in isolation. (Wallace, 2004) The Kaua'i Pain Conference curriculum addresses biopsychosocial dimensions of pain:
Registration for the 30th Napa Pain Conference is now open!
